A Study to Evaluate the Safety, Tolerability, and Drug Levels of BMS-963272 in Participants With Nonalcoholic Fatty Liver Disease
Clinical trial NCT04766476 · TERMINATED
Trial details
- NCT number
- NCT04766476
- Sponsor
- Bristol-Myers Squibb
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-24
- Primary completion
- 2021-08-12
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.